Navigation Links
Alfacell to Present at BIO InvestorForum 2007
Date:10/4/2007

SOMERSET, N.J., Oct. 4 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that Lawrence A. Kenyon, executive vice president, chief financial officer and corporate secretary, will present an overview of the company's product development programs at 2 p.m. PDT on Oct. 11th, at BIO InvestorForum 2007 at the Palace Hotel in San Francisco.

A live audio Webcast of the presentation will be available on Alfacell's Web site at http://www.alfacell.com. A replay of the Webcast will be available online for 90 days.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE(R), is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors. For more information, visit http://www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to s
'/>"/>

SOURCE Alfacell Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...and WALTHAM, Mass., Nov. 19 Arling... find that the leading driver of antibiotic select...ctrum activity against gram-positive and gram-nega...at can cause nosocomial pneumonia, surveyed Europe...agents that provide appropriate coverage against c...
(Date:11/19/2009)... /PRNewswire/ - Aegera Therapeutics Inc. announced...ized Phase 2B study of AEG35156, a targeted antise...ple oncology indications. ,, The study, entitle...-Linked Inhibitor of Apoptosis (XIAP) Antisense AE...ine and Idarubicin in AML Following Failure of a S...
(Date:11/19/2009)...rld,s Top Gene Synthesis Companies Form Internatio... Best Practices in Risk Reduction ,Five Member C...nthesis Capacity , (PRWEB...eading gene synthesis companies today announced ag...otocol to promote biosecurity in the gene synthesi...
(Date:11/19/2009)...ustria, November 19 AFFiRiS AG wil...duct candidate at an unexpectedly early,stage of d...to enter into,Phase II clinical trial early in 201...s the completion of two Phase I trials with the ca... decision on the first interim,analysis of the sec...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...or of information systems and chief financial offi..., Kathi Christian holds positions that sometimes a...aving them combined - primarily, the natural tende...estment for information technology projects - it a...difficult to measure because of the "soft costs" i...
...ting Game , Love Connection , or The Bachelor ...ttle matchmaking of its own. , , DirectorConnector...ompanies with board candidates, has thus far focus...empted to veer into another lane on the informatio...ries about expanding beyond the Midwest from organ...
...,t always please the business traveler, but interc... enterprise than ever before. , ,That,s why techno...s to dismiss the expenses of putting employees on ...deo and mixed-media communication tools. , ,The de... need the spontaneity enabled by high-definition p...
Other Biology Technology:CIO Leadership Series: Kathi Christian, QTI Group 2CIO Leadership Series: Kathi Christian, QTI Group 3CIO Leadership Series: Kathi Christian, QTI Group 4Online service makes board connections 2Online service makes board connections 3IP video goes where air travel cannot 2IP video goes where air travel cannot 3
(Date:11/23/2009)...some of the highest resolution images of peptides ...eeper understanding how biomolecules manipulate th... treatment for kidney stones using biomolecules. ,...ne edition of the journal Proceedings of the Nati...nteract with mineral surfaces by accelerating, swi...
(Date:11/23/2009)... by University of Alabama at Birmingham (UAB) rese...isting medical conditions (co-morbidity) do not ex...n-Americans compared to Caucasians who also have c... in Cancer , a journal of the American Cancer Soc...and co-morbidity are independent predictors of poo...
(Date:11/23/2009)...reveal in unprecedented detail how the ribosome in...ins and guide them toward their destination in bio... flexible fitting (MDFF) to examine the interactio...tners. , The first study, in Proceedings of th...mate signaling between the ribosome and an elongat...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Innovative Dental Education Initiative From Henry Schein ADA And ADEA To Be Featured At ADA Annual Session In Hawaii 5129 1Innovative Dental Education Initiative From Henry Schein ADA And ADEA To Be Featured At ADA Annual Session In Hawaii 5129 2Innovative Dental Education Initiative From Henry Schein ADA And ADEA To Be Featured At ADA Annual Session In Hawaii 5129 3Innovative Dental Education Initiative From Henry Schein ADA And ADEA To Be Featured At ADA Annual Session In Hawaii 5129 4CVS Caremark Launches Distribution of 243 million in Free Seasonal Flu Shot Vouchers to the Unemployed 5125 1CVS Caremark Launches Distribution of 243 million in Free Seasonal Flu Shot Vouchers to the Unemployed 5125 2CVS Caremark Launches Distribution of 243 million in Free Seasonal Flu Shot Vouchers to the Unemployed 5125 3The Most Advanced Solution for the Reduction of Stretch Marks Based on TriPollar 28R 29 Technology Presented at the Upcoming EADV Congress 5121 1The Most Advanced Solution for the Reduction of Stretch Marks Based on TriPollar 28R 29 Technology Presented at the Upcoming EADV Congress 5121 2
...re A*STAR,s Biomedical Research Council, has recei...ibution to cancer research through his discovery o...Medal is one of the highest accolades from the Roy... whose intellectual endeavour have made an impact ...e tumour suppressor, p53, which was discovered bac...
...ising radiation with ever better methods sci-enti...ear age. In addition to natural radiation, mankind...iation which result from the military and technica..., but also for technical and medical applications,...ounts of radionuclides with high precision. On the...
...s at UT Southwestern Medical Center have designed ...by outfitting electrodes with the latest in chemic... formed from carbon nanotubes. , The nanotube she...ed by electrodes, which researchers say is a poten...e stimulation therapy. This type of therapy increa...
Other Biology News:Radioactivity: Discover the lowest amounts with new methods 2Radioactivity: Discover the lowest amounts with new methods 3Coating improves electrical stimulation therapy used for Parkinson's, depression, chronic pain 2
...client/server version of Freezerworks Unlimited in... workflow in high-volume labs and facilitates the ... need to share sample information. Network C...z, PPC 601); 13 in monitor with 256 colors; OS 8.6...
Rabbit Anti-Human PAC1 Antibody, Unconjugated from ABR-Affinity BioReagents
Microplate Rack for Standard Plates from Thermo Scientific
Serum aldolase Colorimetric Assay Kit, Stat-Pack from Caldon Biotech, Inc.
Biology Products: